TBB5 Overview
Molecule Name
Tubulin beta-1 chain
Synonyms
CDCBM6, CSCSC1, M40, OK/SW-cl.56, TUBB1, TUBB5
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs1
Highest Development StageApproved
Target Synonym
Tubulin， Beta 1，Class VI Beta-Tubulin，Tubulin Beta-1 Chain，TUBB1，Tubulin Beta 1 Class VI，DJ543J19.4
Product Inquiry
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| BB-1701 | BB-1701 | Phase 2 Clinical | Bliss Biopharmaceutical (Hangzhou) Co Ltd | Solid tumours; Stomach Neoplasms; Carcinoma, Transitional Cell; Breast Neoplasms; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung | Details |
Marketed Drug Information
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Vindesine sulfate | Compound-112531 | Approved | Eli Lilly And Company | Eldisine | United Kingdom | Small Cell Lung Carcinoma; Breast Neoplasms; Esophageal Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Leukemia; Lymphoma; Melanoma | Eli Lilly And Company | 1979-01-01 | Leukemia; Esophageal Neoplasms; Small Cell Lung Carcinoma; Breast Neoplasms; Lung Neoplasms; Lymphoma; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |